TransGenic Group

TransGenic Group Acquisitions (Net)

The Acquisitions (Net) of TransGenic Group (2342.T) as of Oct 16, 2026 is -112.40 M JPY. In the previous year, Acquisitions (Net) was -15.26 M JPY — a change of 636.54% (lower).

Acquisitions (Net)

-112.40 MJPY

YoY

636.54%

Last updated:

Acquisitions (Net) of TransGenic Group is 2025 -112.40 M JPY. Acquisitions (Net) of TransGenic Group was 2024 -15.26 M JPY. It decreases by 636.54% lower compared to the previous year.

The TransGenic Group Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
-478.03 M JPY
Jan 1, 2019
-514.39 M JPY
Jan 1, 2020
-61.90 M JPY
Jan 1, 2021
194.24 M JPY
Jan 1, 2022
1.51 B JPY
Jan 1, 2023
90.26 M JPY
Jan 1, 2024
-15.26 M JPY
Jan 1, 2025
-112.40 M JPY
The TransGenic Group Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-112.40 MJPY+636.54%
-15.26 MJPY-116.91%
90.26 MJPY-94.04%
1.51 BJPY+679.40%
194.24 MJPY-413.82%
-61.90 MJPY-87.97%
-514.39 MJPY+7.61%
-478.03 MJPY+582.84%
-70.01 MJPY-87.47%
-558.85 MJPY-122,924.84%
455,000.00JPY-100.68%
-66.60 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

TransGenic Group Stock analysis

What does TransGenic Group do? TransGenic Group Inc, listed on the Tokyo Stock Exchange with ticker 2342.T, operates in the Health Care sector within the Biotechnology industry. Based in Fukuoka, Japan, the company employs 236 people. It completed its IPO on December 10, 2002. TransGenic Group develops, distributes, and licenses genetically engineered animals and antibodies. The company reports three business segments: Contract Research Organization (CRO) providing clinical and non-clinical testing services, Diagnostic Analysis offering pathological diagnosis and gene analysis, and TGBS providing business succession support and e-commerce services for electrical products. TransGenic Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TransGenic Group stock

Acquisitions (Net) of TransGenic Group is -112.40 M JPY in 2025.

Acquisitions (Net) of TransGenic Group changed from -15.26 M JPY to -112.40 M JPY, representing a 636.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) TransGenic Group since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s TransGenic Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — TransGenic Group

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — TransGenic Group